Learn More
At the request of the Food and Drug Administration (FDA) and with its funding, the Panel on the Handling of Missing Data in Clinical Trials was created by the National Research Council's Committee on National Statistics. This panel recently published a report(1) with recommendations that will be of use not only to the FDA but also to the entire clinical(More)
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering , and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special(More)
Rob Kass presents a fascinating vision of a " post "-Bayes/frequentist-controversy world in which practical utility of statistical models is the guiding principle for statistical inference. I agree with Kass on many points. In particular, Kass is correct (in my opinion) when he notes that much modern statistical work develops statistical models (the(More)
  • 1